| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.056 | 0.2 |